Celcuity Inc. Common Stock (CELC) Stock Price

CELCStock

$88.44+61.98%52W

Market Cap$4.33B

P/E—

PEG Ratio—

Div yield—

Beta0.09

CELC Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-28.33%

Price vs S&P 500 (4W)-0.72%

VGM Score41.32

CELC Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	-$1.08	-$1.07	+0.93%(+$0.01)
Q1 2026	May 14, 2026	-$0.89	-$0.86	+3.37%(+$0.03)
Q4 2025	Mar 25, 2026	-$1.01	-$0.73	+27.72%(+$0.28)
Q3 2025	Nov 12, 2025	-$0.96	-$0.78	+18.47%(+$0.18)
Q2 2025	Aug 14, 2025	-$0.84	-$0.93	-10.06%(-$0.09)

CELC Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.28

4.33

Industry Peers — Health Services(30)

Symbol	Value Score	Growth Score	Momentum Score	Price
CELCCelcuity Inc. Common Stock	—	—	C	$88.44
NTRANatera, Inc. Common Stock	F	A	B	$326.26
LHLabcorp Holdings Inc.	C	D	B	$335.11
DGXQuest Diagnostics Inc.	C	D	B	$242.76
GHGuardant Health, Inc. Common Stock	F	A	B	$161.50
CAICaris Life Sciences, Inc. Common Stock	F	A	C	$25.63
RDNTRadNet, Inc. Common Stock	D	C	B	$74.61
BLLNBillionToOne, Inc. Class A Common Stock	F	F	D	$93.24
GRALGRAIL, Inc. Common Stock	D	A	B	$80.00
VCYTVeracyte, Inc.	D	A	C	$43.34
CDNACareDx, Inc.	D	B	A	$49.79
PSNLPersonalis, Inc. Common Stock	F	D	A	$17.07
FTREFortrea Holdings Inc. Common Stock	B	F	A	$18.81
FRNMFreenome, Inc. Common stock	—	F	A	$14.79
LMRILumexa Imaging Holdings, Inc. Common Stock	C	C	C	$11.51
CSTLCastle Biosciences, Inc. Common Stock	D	B	B	$33.50
FLGTFulgent Genetics, Inc. Common Stock	C	D	C	$19.61
YDESYD Bio Limited Ordinary Shares	—	—	C	$4.80
BDSXBiodesix, Inc. Common Stock	D	B	A	$26.83
XGNExagen Inc. Common Stock	D	B	C	$7.39
PCSCPerceptive Capital Solutions Corp Class A Ordinary Shares	—	F	B	$11.95
BNRBurning Rock Biotech Limited American Depositary Shares	B	F	D	$10.19
SERASera Prognostics, Inc. Class A Common Stock	D	D	D	$2.07
MDXHMDxHealth SA Ordinary Shares	B	B	F	$0.72
ADVBAdvanced Biomed Inc. Common Stock	A	—	A	$9.70
AMSAmerican Shared Hospital Services	A	C	D	$1.47
ACONAclarion, Inc. Common Stock	—	B	F	$2.40
BGLCBioNexus Gene Lab Corp Common stock	B	F	F	$1.55
ACONWAclarion, Inc. Warrant	—	—	C	$0.03
EXASExact Sciences Corp	F	B	B	$0.00
YDESWYD Bio Limited Warrants	—	—	D	$0.42

About Celcuity Inc. Common Stock

Celcuity is a clinical-stage oncology biotechnology company developing gedatolisib, a dual PI3K/mTOR inhibitor with a differentiated mechanism of action compared to existing therapies. The company's lead program is in Phase 3 development (VIKTORIA-1), evaluating gedatolisib combined with fulvestrant with or without palbociclib for hormone receptor-positive, HER2-negative advanced breast cancer.